Searched for
VALEANT PHARMA
Should health issues of senior execs be part of corp disclosure?The question is tricky as it is situated on the crossroads of the rights of the investors to know and the right of privacy of the individua...- Decoding the impact of Ilumya, Sun Pharma's first biologic drug approved by the US FDALast year Sun Pharma signed another deal with South Korea's Samsung Biologics to get the drug manufactured on approval.
- Alembic Pharma gets USFDA nod for Acyclovir ointmentThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembi...
- Doklam effect? India said to block Fosun's $1.3 billion Gland purchaseThe companies haven’t been formally notified yet of the move, the people said, asking not to be identified because the information is priva...
- Jubilant Life Sciences gets USFDA nod for anti-depressive drugThe approved product is the generic version of Wellbutrin XL of Valeant, which is used for the treatment of major depressive disorder and p...
- Strides Shasun frontrunner to buy iNova Pharma: SourceAt 10:00 am, shares of Strides Shasun were trading 1 per cent higher at Rs 1,100. It hit a low of Rs 1,085 and a high of Rs 1,109 in the fi...
- Should you buy pharma stocks if Hillary Clinton wins?According to data from Bloomberg, branded drugs with more than $14 billion in annual sales will lose patent protection in 2017.
- Taro drug pricing probe may widen to other generic drug makersResearch by IIFL shows several generic drug companies, including a few top Indian generic drug makers, effected steep price increases withi...
- With an aim of expansion, pharma companies like Lupin and Torrent eyeing overseas acquisitionThey are scouting for niche manufacturing sites, promising experimental drugs, specialty firms in emerging markets and opportunities in the...
- What changed for markets while you were sleepingWall Street remained edgy in overnight trade ahead of the outcome of US Fed’s rate-setting meeting later today while most Asian markets are...
- Aurobindo Pharma gets USFDA nod for acid reflux treatment drugAurobindo Pharma has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux...
- Lupin appoints Martin Mercer as head of Latin American businessThe Latin American region is a market of strategic focus for the company and one of the fastest growing pharmaceutical markets globally, sh...
- Aurobindo Pharma may launch Tramadol tablets in US market from JanuaryAccording to a statement issue by the company, it received final approval from the USFDA to manufacture and market the drug.
- Bill Ackman gets a taste of his own medicine as Citron Research says Valeant Pharma inflating sales figuresValeant plunged as much as 40%, prompting a public response from the company and creating billions of dollars of losses for its hedge fund ...
- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...
- Sun Pharma gets USFDA nod for generic cardiac capsulesDiltiazem HCl extended-release capsules are indicated for the treatment of hypertension and for the management of angina.
- Teva to buy Taiyo stake for $460 million, bid for restTeva Pharmaceutical Industries Ltd agreed to buy 57% of Taiyo Pharmaceutical Industry Co Ltd. for $460 million and bid for the rest.
- Indian pharma firms expand global footprint in 2006Indian pharmaceutical companies' huge appetite to expand overseas through acquisitions, while being at loggerheads with the government at h...
- Sun Pharma scouts for supply tie-ups in EuropeMumbai-based Sun Pharma is about to give its bulk drug business a shot in the arm - it’s scouting for tie-ups in Europe to supply a range o...
- Indian drug cos reel under US pricing pressuresIn spite of new product launches, the US pharmaceutical generic market continues to reel under pricing pressure, increasing competition and...
Load More
